tiprankstipranks
Trending News
More News >
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market
Advertisement

Aridis Pharmaceuticals (ARDS) Drug Pipeline

Compare
207 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Suvratoxumab
Ventilator Associated Pneumonia, Staphylococcus Aureus
Phase III
Terminated
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Apr 01, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Aridis Pharmaceuticals (ARDS) have in its pipeline
      ARDS is currently developing the following drugs: Suvratoxumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis